<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>2301-1254</journal-id>
<journal-title><![CDATA[Anales de la Facultad de Medicina]]></journal-title>
<abbrev-journal-title><![CDATA[Anfamed]]></abbrev-journal-title>
<issn>2301-1254</issn>
<publisher>
<publisher-name><![CDATA[Universidad de la República. Facultad de Medicina]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S2301-12542024000201205</article-id>
<article-id pub-id-type="doi">10.25184/anfamed2024v11n2a9</article-id>
<title-group>
<article-title xml:lang="es"><![CDATA[Eventos adversos de la vacuna contra SARS-CoV-2 en una muestra pediátrica uruguaya.]]></article-title>
<article-title xml:lang="en"><![CDATA[Adverse events of the vaccine against SARS-CoV-2 in an Uruguayan pediatric sample.]]></article-title>
<article-title xml:lang="pt"><![CDATA[Eventos adversos da vacina contra SARS-CoV-2 na amostra pediátrica uruguaia.]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Trujillo]]></surname>
<given-names><![CDATA[Janet]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Correa]]></surname>
<given-names><![CDATA[Matías]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Madamo]]></surname>
<given-names><![CDATA[Agustina]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Alvarez]]></surname>
<given-names><![CDATA[Cecilia Beatriz]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Pintos]]></surname>
<given-names><![CDATA[Javier]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Aguirrezábal]]></surname>
<given-names><![CDATA[Patricia]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Inthamoussu]]></surname>
<given-names><![CDATA[Maite]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Speranza]]></surname>
<given-names><![CDATA[Noelia]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Pujadas]]></surname>
<given-names><![CDATA[Mónica]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Alemán]]></surname>
<given-names><![CDATA[Alicia]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
</contrib-group>
<aff id="Af1">
<institution><![CDATA[,Universidad de la República Facultad de Medicina Departamento de Medicina Preventiva y Social]]></institution>
<addr-line><![CDATA[ ]]></addr-line>
<country>Uruguay</country>
</aff>
<aff id="Af2">
<institution><![CDATA[,Universidad de la República Facultad de Medicina Departamento de Farmacología y Terapéutica]]></institution>
<addr-line><![CDATA[ ]]></addr-line>
<country>Uruguay</country>
</aff>
<aff id="Af3">
<institution><![CDATA[,Universidad de la República Facultad de Medicina Clínica Pediátrica A, Departamento de Pediatría]]></institution>
<addr-line><![CDATA[ ]]></addr-line>
<country>Uruguay</country>
</aff>
<pub-date pub-type="pub">
<day>00</day>
<month>12</month>
<year>2024</year>
</pub-date>
<pub-date pub-type="epub">
<day>00</day>
<month>12</month>
<year>2024</year>
</pub-date>
<volume>11</volume>
<numero>2</numero>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://www.scielo.edu.uy/scielo.php?script=sci_arttext&amp;pid=S2301-12542024000201205&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.edu.uy/scielo.php?script=sci_abstract&amp;pid=S2301-12542024000201205&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.edu.uy/scielo.php?script=sci_pdf&amp;pid=S2301-12542024000201205&amp;lng=en&amp;nrm=iso"></self-uri><abstract abstract-type="short" xml:lang="es"><p><![CDATA[RESUMEN En nuestro país, se recomendó el uso de la vacuna Pfizer/BioNTech en niños/as de 5 y 11 años desde diciembre/2021, en dos dosis separadas por seis semanas. Es necesario una mayor valoración de la vacuna debido a su rápido proceso de aprobación. El objetivo del estudio fue determinar la ocurrencia de eventos supuestamente atribuibles a la vacunación e inmunización (ESAVI) contra SARS-CoV-2 en niños/as de 5 y 11 años. Se realizó un estudio descriptivo. Se incluyeron niños/as menores de 12 años con exámenes de sangre por indicación médica en el laboratorio del Centro Hospitalario Pereira Rossell entre noviembre de 2021/2022. Fueron colectados datos de: ESAVI, estado vacunal, edad y sexo mediante encuesta e historia clínica. Las variables se analizaron por estadística descriptiva. Participaron del estudio 141 niños/as entre 5 y menores de 12 años, de estos, un 53,9% (n=74) recibieron la vacuna. Su edad media fue 8,4 (2,1) años y 47,3% eran de sexo femenino. Los ESAVI más frecuentes tras la primera dosis fueron: malestar general (n=8) y cefalea (n=9). En la zona de vacunación fueron: dolor (n=30) y endurecimiento (n=10). En la segunda dosis, los más frecuentes fueron: cefalea y fiebre (n= 3) y los locales fueron: dolor (n=13) y endurecimiento (n=4). Estos síntomas se presentaron más frecuentemente en los primeros tres días post-vacunación en ambas dosis. Estos resultados nos permiten concluir que los ESAVI encontrados fueron leves, más frecuentemente locales y en un periodo corto de tiempo post-vacunación.]]></p></abstract>
<abstract abstract-type="short" xml:lang="en"><p><![CDATA[ABSTRACT In our country, in children aged 5 and 11 years, the use of the Pfizer/BioNTech vaccine has been recommended since December/2021, in two doses separated by six weeks. Further vaccine evaluation is necessary due to its rapid approval process. The aim of this study was to determine the occurrence of events supposedly attributable to vaccination or immunization (ESAVI) against the SARS-CoV-2 in children from 5 and 11 years. A descriptive study was carried out. Children under 12 years of age were included with blood tests ordered by the doctor in the laboratory of the Pereira Rossell Hospital Center between November 2021/2022. Data were collected on: ESAVI, vaccination status, age and sex through a survey and clinical history. The variables were analyzed by descriptive statistics. There were 141 children between 5 and younger than 12 years who participated in the study; of these, 53.9% (n=74) received the vaccine. Their mean age was 8.4 (2.1) years and 47.3% were female. The most frequent ESAVI after the first dose were: general discomfort (n=8) and headache (n=9). In the vaccination area, they were: pain (n=30) and hardening (n=10). In the second dose, the most frequent were: headache and fever (n=3) and the local ones were: pain (n=13) and hardening (n=4). These symptoms occurred more frequently in the first three days post-vaccination in both doses. These results allow us to conclude that the ESAVI found were mild, more frequently local and in a short period of time post-vaccination.]]></p></abstract>
<abstract abstract-type="short" xml:lang="pt"><p><![CDATA[RESUMO Em nosso país, nas crianças de 5 e 11 anos, foi recomendado o uso da vacina Pfizer/BioNTech desde dezembro/2021, em duas doses separadas por seis semanas. É necessária uma maior valorização da vacina devido ao seu rápido processo de aprovação. O objetivo do estudo foi determinar a ocorrência de eventos supostamente atribuíveis à vacinação ou imunização (ESAVI) contra SARS-CoV-2 em crianças entre 5 e 11 anos. Foi realizado um estudo descritivo. Se incluíram crianças menores de 12 anos com exames de sangue indicados pelo médico no laboratório do Centro Hospitalario Pereira Rossell entre novembro de 2021/2022. Fueron coletados dados de: ESAVI, estado vacinal, idade e sexo por meio de um inquerito e da história clínica. As variáveis &#8203;&#8203;foram analisadas por estatística descritiva. Participaram do estudo 141 crianças entre 5 e menores de 12 anos, destes, um 53,9% (n=74) recebeu a vacina. Sua idade média foi de 8,4 (2,1) anos e 47,3% era de sexo feminino. Os ESAVI mais frequentes após a primeira dose foram: desconforto geral (n=8) e cefaléia (n=9). Na zona de vacinação foram: dor (n=30) e endurecimento (n=10). Na segunda dose, os ESAVI mais frequentes foram: cefaléia e febre (n=3) e os locais foram: dor (n=13) e endurecimento (n=4). Esses sintomas foram apresentados com mais frequência nos primeiros três dias pós-vacinação nas duas doses. Esses resultados nos permitem concluir que os ESAVI encontrados foram leves, mais frequentemente locais e num período curto de tempo pós-vacinação.]]></p></abstract>
<kwd-group>
<kwd lng="es"><![CDATA[vacuna]]></kwd>
<kwd lng="es"><![CDATA[SARS-CoV-2]]></kwd>
<kwd lng="es"><![CDATA[Vigilancia en salud]]></kwd>
<kwd lng="es"><![CDATA[Niño]]></kwd>
<kwd lng="es"><![CDATA[Seguridad]]></kwd>
<kwd lng="en"><![CDATA[Vaccine]]></kwd>
<kwd lng="en"><![CDATA[SARS-CoV-2]]></kwd>
<kwd lng="en"><![CDATA[Health Surveillance]]></kwd>
<kwd lng="en"><![CDATA[Child]]></kwd>
<kwd lng="en"><![CDATA[Safety]]></kwd>
<kwd lng="pt"><![CDATA[vacina]]></kwd>
<kwd lng="pt"><![CDATA[SARS-CoV-2]]></kwd>
<kwd lng="pt"><![CDATA[Vigilância em Saúde]]></kwd>
<kwd lng="pt"><![CDATA[Criança]]></kwd>
<kwd lng="pt"><![CDATA[Segurança]]></kwd>
</kwd-group>
</article-meta>
</front><back>
<ref-list>
<ref id="B1">
<label>1</label><nlm-citation citation-type="book">
<collab>World Health Organization</collab>
<source><![CDATA[COVID-19 disease in children and adolescents: scientific brief, 29 September 2021 (Internet)]]></source>
<year>2021</year>
<publisher-loc><![CDATA[Geneva ]]></publisher-loc>
<publisher-name><![CDATA[World Health Organization]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B2">
<label>2</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Martin]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
<name>
<surname><![CDATA[DeWitt]]></surname>
<given-names><![CDATA[PE]]></given-names>
</name>
<name>
<surname><![CDATA[Russell]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Anand]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Bradwell]]></surname>
<given-names><![CDATA[KR]]></given-names>
</name>
<name>
<surname><![CDATA[Bremer]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Characteristics, Outcomes, and Severity Risk Factors Associated With SARS-CoV-2 Infection Among Children in the US National COVID Cohort Collaborative]]></article-title>
<source><![CDATA[JAMA Network Open]]></source>
<year>2022</year>
<volume>5</volume>
<numero>2</numero>
<issue>2</issue>
</nlm-citation>
</ref>
<ref id="B3">
<label>3</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Guimarães]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Pissarra]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Reis-Melo]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Guimarães]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Multisystem inflammatory syndrome in children (MISC) A systematic review]]></article-title>
<source><![CDATA[Int J Clin Pract]]></source>
<year>2021</year>
<volume>75</volume>
<numero>11</numero>
<issue>11</issue>
</nlm-citation>
</ref>
<ref id="B4">
<label>4</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Bhuiyan]]></surname>
<given-names><![CDATA[MU]]></given-names>
</name>
<name>
<surname><![CDATA[Stiboy]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Hassan]]></surname>
<given-names><![CDATA[MZ]]></given-names>
</name>
<name>
<surname><![CDATA[Chan]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Islam]]></surname>
<given-names><![CDATA[MS]]></given-names>
</name>
<name>
<surname><![CDATA[Haider]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Epidemiology of COVID-19 infection in young children under five years A systematic review and meta-analysis]]></article-title>
<source><![CDATA[Vaccine]]></source>
<year>2021</year>
<volume>39</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>667-77</page-range></nlm-citation>
</ref>
<ref id="B5">
<label>5</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[de Souza]]></surname>
<given-names><![CDATA[TH]]></given-names>
</name>
<name>
<surname><![CDATA[Nadal]]></surname>
<given-names><![CDATA[JA]]></given-names>
</name>
<name>
<surname><![CDATA[Nogueira]]></surname>
<given-names><![CDATA[RJN]]></given-names>
</name>
<name>
<surname><![CDATA[Pereira]]></surname>
<given-names><![CDATA[RM]]></given-names>
</name>
<name>
<surname><![CDATA[Brandão]]></surname>
<given-names><![CDATA[MB]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Clinical manifestations of children with COVID-19 A systematic review]]></article-title>
<source><![CDATA[Pediatr Pulmonol]]></source>
<year>2020</year>
<volume>55</volume>
<numero>8</numero>
<issue>8</issue>
<page-range>1892-9</page-range></nlm-citation>
</ref>
<ref id="B6">
<label>6</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Viner]]></surname>
<given-names><![CDATA[RM]]></given-names>
</name>
<name>
<surname><![CDATA[Ward]]></surname>
<given-names><![CDATA[JL]]></given-names>
</name>
<name>
<surname><![CDATA[Hudson]]></surname>
<given-names><![CDATA[LD]]></given-names>
</name>
<name>
<surname><![CDATA[Ashe]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Patel]]></surname>
<given-names><![CDATA[SV]]></given-names>
</name>
<name>
<surname><![CDATA[Hargreaves]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Systematic review of reviews of symptoms and signs of COVID-19 in children and adolescents]]></article-title>
<source><![CDATA[Arch Dis Child]]></source>
<year>2021</year>
<volume>106</volume>
<numero>8</numero>
<issue>8</issue>
<page-range>802-7</page-range></nlm-citation>
</ref>
<ref id="B7">
<label>7</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Di Nardo]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[van Leeuwen]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Loreti]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Barbieri]]></surname>
<given-names><![CDATA[MA]]></given-names>
</name>
<name>
<surname><![CDATA[Guner]]></surname>
<given-names><![CDATA[Y]]></given-names>
</name>
<name>
<surname><![CDATA[Locatelli]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[A literature review of 2019 novel coronavirus (SARS-CoV2) infection in neonates and children]]></article-title>
<source><![CDATA[Pediatr Res]]></source>
<year>2021</year>
<volume>89</volume>
<numero>5</numero>
<issue>5</issue>
<page-range>1101-8</page-range></nlm-citation>
</ref>
<ref id="B8">
<label>8</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Díaz]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Cimarra]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Montes de Oca]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Agorio]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Galíndez]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Pujadas]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Infección por SARS-CoV-2 COVID-19: seguimiento de casos sospechosos y contactos en la población pediátrica de un hospital de tercer nivel]]></article-title>
<source><![CDATA[Archivos de Pediatría del Uruguay]]></source>
<year>2022</year>
<volume>93</volume>
<numero>NSPE1</numero>
<issue>NSPE1</issue>
</nlm-citation>
</ref>
<ref id="B9">
<label>9</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Aguirre]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Sánchez]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Bazzino]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Pírez]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Aguirre]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Sánchez]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[COVID-19 en la edad pediátrica. Descripción clínico-epidemiológica de pacientes asistidos en el Hospital Británico (Montevideo, Uruguay). Período marzo 2020-mayo 2021.]]></article-title>
<source><![CDATA[Archivos de Pediatría del Uruguay]]></source>
<year>2022</year>
<volume>93</volume>
<numero>NSPE1</numero>
<issue>NSPE1</issue>
</nlm-citation>
</ref>
<ref id="B10">
<label>10</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Giachetto]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Mauvezin]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Pardo]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Barrios]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Dabezies]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Martínez]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Características epidemiológicas y clínicas de los niños con COVID-19 asistidos en un prestador de salud privado de Uruguay]]></article-title>
<source><![CDATA[Revista chilena de infectología]]></source>
<year>2022</year>
<volume>39</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>53-8</page-range></nlm-citation>
</ref>
<ref id="B11">
<label>11</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Pujadas]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Viera]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Galiana]]></surname>
<given-names><![CDATA[Á]]></given-names>
</name>
<name>
<surname><![CDATA[Pírez]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[García]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Kenny]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Vigilancia de la infección por SARS-CoV-2 COVID-19 en un hospital pediátrico]]></article-title>
<source><![CDATA[Archivos de Pediatría del Uruguay]]></source>
<year>2022</year>
<volume>93</volume>
<numero>S1</numero>
<issue>S1</issue>
<page-range>e215</page-range></nlm-citation>
</ref>
<ref id="B12">
<label>12</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Morello]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Martino]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Buonsenso]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Diagnosis and management of post-COVID (Long COVID) in children a moving target]]></article-title>
<source><![CDATA[Curr Opin Pediatr]]></source>
<year>2023</year>
<volume>35</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>184-92</page-range></nlm-citation>
</ref>
<ref id="B13">
<label>13</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Martínez]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
<name>
<surname><![CDATA[Venturino]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Gíbara]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Mata]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Cabrera]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Finozzi]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Síndrome multisistémico post COVID-19 y dificultad en su diagnóstico etiológico A propósito de un caso clínico]]></article-title>
<source><![CDATA[Archivos de Pediatría del Uruguay]]></source>
<year>2022</year>
<volume>93</volume>
<numero>S1</numero>
<issue>S1</issue>
<page-range>e313</page-range></nlm-citation>
</ref>
<ref id="B14">
<label>14</label><nlm-citation citation-type="book">
<source><![CDATA[COVID-19 Actualización al 13 de diciembre de 2021]]></source>
<year>2021</year>
<publisher-name><![CDATA[MSP]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B15">
<label>15</label><nlm-citation citation-type="book">
<source><![CDATA[Infección por SARS-CoV-2 covid-19 en niños y adolescentes. Actualización de definiciones de caso e indicación de testeo Julio de 2021]]></source>
<year>2021</year>
<publisher-name><![CDATA[MSP]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B16">
<label>16</label><nlm-citation citation-type="book">
<source><![CDATA[Why COVID-19 Vaccines are Important for Children]]></source>
<year>2022</year>
<publisher-name><![CDATA[American Academy of Pediatrics]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B17">
<label>17</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Dabezies]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Goldaraz]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Mauvezin]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Giachetto]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Dinámica de la transmisión de SARS-CoV-2 en centros educativos en un prestador de salud privado en Uruguay]]></article-title>
<source><![CDATA[Archivos de Pediatría del Uruguay]]></source>
<year>2022</year>
<volume>93</volume>
<numero>S2</numero>
<issue>S2</issue>
<page-range>e227</page-range></nlm-citation>
</ref>
<ref id="B18">
<label>18</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Amaya]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Santoro]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Fernández]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
<name>
<surname><![CDATA[Dewaele]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Factores asociados a la positividad de la PCR para SARS-CoV-2 en menores de 15 años]]></article-title>
<source><![CDATA[Archivos de Pediatría del]]></source>
<year>2022</year>
<volume>93</volume>
<numero>S2</numero>
<issue>S2</issue>
<page-range>e226</page-range></nlm-citation>
</ref>
<ref id="B19">
<label>19</label><nlm-citation citation-type="book">
<source><![CDATA[Actualización sobre el coronavirus (COVID-19): La FDA autoriza las vacunas contra el COVID-19 de Moderna y Pfizer-BioNTech para niños a partir de los seis meses de edad]]></source>
<year>2022</year>
<publisher-name><![CDATA[FDA]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B20">
<label>20</label><nlm-citation citation-type="">
<source><![CDATA[En enero comienza vacunación contra covid en niños entre 5 y 11 años]]></source>
<year>2021</year>
</nlm-citation>
</ref>
<ref id="B21">
<label>21</label><nlm-citation citation-type="">
<source><![CDATA[Pfizer-BioNTech COVID-19 Vaccine. FDA]]></source>
<year>2024</year>
</nlm-citation>
</ref>
<ref id="B22">
<label>22</label><nlm-citation citation-type="">
<source><![CDATA[COVID-19 medicines. European Medicines Agency (EMA)]]></source>
<year></year>
</nlm-citation>
</ref>
<ref id="B23">
<label>23</label><nlm-citation citation-type="book">
<source><![CDATA[Informe técnico: Vacunación contra COVID-19 en población pediátrica de 5 a 11 años]]></source>
<year>2021</year>
<publisher-name><![CDATA[MSP]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B24">
<label>24</label><nlm-citation citation-type="book">
<source><![CDATA[Esquema de vacunación contra covid-19]]></source>
<year>2024</year>
<publisher-name><![CDATA[MSP]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B25">
<label>25</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Walter]]></surname>
<given-names><![CDATA[EB]]></given-names>
</name>
<name>
<surname><![CDATA[Talaat]]></surname>
<given-names><![CDATA[KR]]></given-names>
</name>
<name>
<surname><![CDATA[Sabharwal]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Gurtman]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Lockhart]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Paulsen]]></surname>
<given-names><![CDATA[GC]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Evaluation of the BNT162b2 Covid-19 Vaccine in Children 5 to 11 Years of Age]]></article-title>
<source><![CDATA[N Engl J Med]]></source>
<year>2022</year>
<volume>386</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>35-46</page-range></nlm-citation>
</ref>
<ref id="B26">
<label>26</label><nlm-citation citation-type="book">
<collab>OMS</collab>
<source><![CDATA[COVID-19 vaccines: safety surveillance manual]]></source>
<year>2020</year>
<publisher-name><![CDATA[OMS]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B27">
<label>27</label><nlm-citation citation-type="book">
<source><![CDATA[RStudio: Integrated Development Environment for R]]></source>
<year>2023</year>
<publisher-loc><![CDATA[Boston, MA ]]></publisher-loc>
<publisher-name><![CDATA[PBC]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B28">
<label>28</label><nlm-citation citation-type="book">
<collab>MSP</collab>
<source><![CDATA[Respuesta y resolución 2267]]></source>
<year>2023</year>
<publisher-name><![CDATA[MSP]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B29">
<label>29</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Malden]]></surname>
<given-names><![CDATA[DE]]></given-names>
</name>
<name>
<surname><![CDATA[Gee]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Glenn]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Li]]></surname>
<given-names><![CDATA[Z]]></given-names>
</name>
<name>
<surname><![CDATA[Mercado]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Ogun]]></surname>
<given-names><![CDATA[OA]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Reactions following Pfizer-BioNTech COVID-19 mRNA vaccination and related healthcare encounters among 7,077 children aged 5-11 years within an integrated healthcare system]]></article-title>
<source><![CDATA[Vaccine]]></source>
<year>2023</year>
<volume>41</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>315-22</page-range></nlm-citation>
</ref>
<ref id="B30">
<label>30</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Hause]]></surname>
<given-names><![CDATA[AM]]></given-names>
</name>
<name>
<surname><![CDATA[Baggs]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Marquez]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Myers]]></surname>
<given-names><![CDATA[TR]]></given-names>
</name>
<name>
<surname><![CDATA[Gee]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Su]]></surname>
<given-names><![CDATA[JR]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[COVID-19 Vaccine Safety in Children Aged 5-11 Years - United States, November 3-December 19, 2021]]></article-title>
<source><![CDATA[MMWR Morb Mortal Wkly Rep]]></source>
<year>2021</year>
<volume>70</volume>
<numero>5152</numero>
<issue>5152</issue>
<page-range>1755-60</page-range></nlm-citation>
</ref>
<ref id="B31">
<label>31</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Capponi]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Pulvirenti]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Cinicola]]></surname>
<given-names><![CDATA[BL]]></given-names>
</name>
<name>
<surname><![CDATA[Brindisi]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Conti]]></surname>
<given-names><![CDATA[MG]]></given-names>
</name>
<name>
<surname><![CDATA[Colaiocco]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Short-Term Side Effects and SARS-CoV-2 Infection after COVID-19 Pfizer-BioNTech Vaccine in Children Aged 5-11 Years An Italian Real-World Study]]></article-title>
<source><![CDATA[Vaccines]]></source>
<year>2022</year>
<volume>10</volume>
<numero>7</numero>
<issue>7</issue>
<page-range>1056</page-range></nlm-citation>
</ref>
<ref id="B32">
<label>32</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Piechotta]]></surname>
<given-names><![CDATA[V]]></given-names>
</name>
<name>
<surname><![CDATA[Siemens]]></surname>
<given-names><![CDATA[W]]></given-names>
</name>
<name>
<surname><![CDATA[Thielemann]]></surname>
<given-names><![CDATA[I]]></given-names>
</name>
<name>
<surname><![CDATA[Toews]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Koch]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Vygen-Bonnet]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Safety and effectiveness of vaccines against COVID-19 in children aged 5-11 years a systematic review and meta-analysis]]></article-title>
<source><![CDATA[Lancet Child Adolesc Health]]></source>
<year>2023</year>
<volume>7</volume>
<numero>6</numero>
<issue>6</issue>
<page-range>379-91</page-range></nlm-citation>
</ref>
<ref id="B33">
<label>33</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Copland]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Patone]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Saatci]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Handunnetthi]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Hirst]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Hunt]]></surname>
<given-names><![CDATA[DPJ]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Safety outcomes following COVID-19 vaccination and infection in 5 1 million children in England]]></article-title>
<source><![CDATA[Nat Commun]]></source>
<year>2024</year>
<volume>15</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>3822</page-range></nlm-citation>
</ref>
</ref-list>
</back>
</article>
